Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IgG Deficiency”

48 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 48 results

Large-scale testing (Phase 3)Study completedNCT00168012
What this trial is testing

Efficacy and Safety of Intravenous Immunoglobulin IVIG-F10 in Patients With Primary Immunodeficiencies (PID)

Who this might be right for
AgammaglobulinemiaIgG DeficiencyCommon Variable Immunodeficiency
CSL Behring 42
Post-approval studies (Phase 4)Study completedNCT02881437
What this trial is testing

IgG Level in Primary Immunodeficiency Switching From Standard SCIG to Every Other Week HyQvia

Who this might be right for
Primary Immunodeficiency
University Hospital, Lille 22
Not applicableStudy completedNCT01166074
What this trial is testing

Retrospective Chart Review of Subcutaneous IgG Use in Infants

Who this might be right for
Primary Immune Deficiency
CSL Behring 27
Large-scale testing (Phase 3)UnknownNCT01992328
What this trial is testing

IVIG Treatment for Asthmatic Patients With IgG Subclass Deficiency

Who this might be right for
Asthma
Ajou University School of Medicine 30
Post-approval studies (Phase 4)Study completedNCT00522821
What this trial is testing

Treatment of Deficient Subclass or Anti-polysaccharide Antibody Response

Who this might be right for
IgG DeficiencyInfections
Prothya Biosolutions 55
Post-approval studies (Phase 4)Study completedNCT00520494
What this trial is testing

Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency

Who this might be right for
Common Variable ImmunodeficiencyAgammaglobulinemia
CSL Behring 18
Early research (Phase 1)Study completedNCT00000976
What this trial is testing

A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related Complex

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 40
Not applicableStudy completedNCT00000647
What this trial is testing

An Open Trial Combining Zidovudine, Interferon-alfa, and Recombinant CD4-IgG With Transplantation of Syngeneic Bone Marrow and Peripheral Blood Lymphocytes From Healthy gp160-Immunized Donors in the Treatment of Patients With HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 6
Large-scale testing (Phase 3)Study completedNCT00419341
What this trial is testing

Study of Subcutaneous Immunoglobulin in Patients With PID Requiring IgG Replacement Therapy

Who this might be right for
Primary Immune Deficiency
CSL Behring 49
Large-scale testing (Phase 3)Study completedNCT00680446
What this trial is testing

Safety Study of Subcutaneous Ig NextGen 16% in Patients With Primary Immunodeficiency

Who this might be right for
Primary Immune Deficiency
CSL Limited 41
Not applicableStudy completedNCT05447065
What this trial is testing

Impact of Vitamin D Supplementation on COVID-19 Vaccine Response and IgG Antibodies in Deficient Women.

Who this might be right for
COVID-19 PandemicD Vitamin DeficiencyAntibody Hypersensitivity
Ege University 33
Not applicableStudy completedNCT03369301
What this trial is testing

The Effect of Subcutaneous Immunoglobulin Gammanorm on the Distribution of IgG Subclasses and on Immunity of Patients With Secondary Immunodeficiency

Who this might be right for
Secondary Immune Deficiency
Octapharma 102
Not applicableUnknownNCT01981785
What this trial is testing

Investigation of Immune Disorders and Deficiencies

Who this might be right for
Primary Immune DeficienciesAutoimmune DiseasesInflammatory Diseases+2 more
O & O Alpan LLC 343
Not applicableStudy completedNCT04818177
What this trial is testing

Immunoglobulin G Therapy Dose Optimization

Who this might be right for
ObesityImmune Deficiency
Rutgers, The State University of New Jersey 40
Testing effectiveness (Phase 2)Study completedNCT00417573
What this trial is testing

Efficacy of IgIv in Patients With IgG Subclass Deficiency and Recurrent Infections

Who this might be right for
IgG DeficiencyInfections
The Center for Rheumatic Disease, Allergy, & Immunology 10
Not applicableUnknownNCT03357978
What this trial is testing

Susceptibility to Infections, Tumor Risk and Liver Disease in Patients With Ataxia Telangiectasia

Who this might be right for
Ataxia Telangiectasia
Johann Wolfgang Goethe University Hospital 30
Not applicableUnknownNCT04736524
What this trial is testing

Immune Response Following COVID-19 Vaccination

Who this might be right for
IgM and IgG in Blood
Texas Cardiac Arrhythmia Research Foundation 500
Post-approval studies (Phase 4)Looking for participantsNCT05193552
What this trial is testing

Usage of Spirometry in Managing IgG Therapy in CVID with Airway Disease

Who this might be right for
Common Variable Immunodeficiency
University of Alabama at Birmingham 22
Not applicableUnknownNCT01646411
What this trial is testing

300 Antibody Diagnostic Test Kit

Who this might be right for
Acute Bacterial InfectionsAcute Viral Infections
The Plasma Source 300
Early research (Phase 1)Study completedNCT00000663
What this trial is testing

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 18
Load More Results